Annals of Medicine
Volume 55, 2023 - Issue 1
Open access
1,625
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in uterine serous carcinoma
Wesley C. Burketta Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, NC
, Ziyi Zhaoa Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, NC;b Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health care Hospital, Beijing, P. R. China
, Meredith A. Newtona Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, NC
, Wenchuan Suna Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, NC
, Boer Denga Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, NC;b Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health care Hospital, Beijing, P. R. China
, Angeles Alvarez Secordc Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University, Durham, NC
, Chunxiao Zhoua Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, NC;d Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NCCorrespondence[email protected]
& Victoria Bae-Jumpa Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, NC;d Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NCCorrespondence[email protected]
show all
Pages 603-614
|
Received 12 Jul 2022, Accepted 03 Feb 2023, Published online: 11 Feb 2023
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.